Review Article

Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis

Table 1

Eligible studies’ characteristics.

#YearAntibody typeDilutionBufferpHT (°C)Grading systemSS sampleNSS sampleEntire sample

[16]2015Rabbit polyclonal1 : 200PBS7.2NR17472146
[17]2016Mouse polyclonal1 : 150Citrate695226733
[18]2013Rabbit polyclonal1 : 25EDTA9951, 2, 45085135
[19]2011Rabbit polyclonal1 : 400Citrate697373139212
[20]2016Rabbit polyclonal1 : 100EDTA695262322384
[21]2009Rabbit polyclonal1 : 20EDTA8.4ND23573108
[22]2010Rabbit polyclonal1 : 100EDTA8.495425960319
[23]2009Rabbit polyclonal1 : 100EDTA897120143163
[24]2011Rabbit polyclonal1 : 20EDTA8956152540
[25]2012Rabbit polyclonal1 : 250EDTA89714269111
[26]2017Mouse monoclonal
Rabbit polyclonal
NRCitrateNR927101222
[27]2007Rabbit polyclonal
Rat monoclonal
1 : 20
1 : 2
EDTA895294602696
[28]2013Rabbit polyclonal1 : 100EDTA695553742

Abbreviations: SS: synovial sarcoma; NSS: nonsynovial sarcoma; PBS: phosphate-buffered saline; EDTA: ethylenediaminetetraacetic acid; NR: not reported; ND: no details. Grading system 1: 0 (<5% of cells positive); 1 (5–25% of cells positive); 2 (25–50% of cells positive); 3 (>50% of cells positive); Grading system 2: 0 (staining not visible); 1 (<26% of cells positive); 2 (26–50% of cells positive at 40x or >50% at 100x objectives); 3 (>50% of cells positive at 40x); Grading system 3: 0 (staining not visible); 1 (<5% of cells positive); 2 (6–25% of cells positive); 3 (26–50% of cells positive); 4 (51–75% of cells positive); 5 (>75% of cells positive); Grading system 4: 0 (no staining); 1 (<10% of cells positive); 2 (11–50% of cells positive); 3 (51–80% of cells positive); 4 (>80% of cells positive); Grading system 5: >20% of cells positive; Grading system 6: 0 (negative); 1 (weak); 2 (moderate); 3 (strong); Grading system 7: 0 (<5% of cells positive); 1 (5–25% of cells positive); 2 (25–50% of cells positive); 3 (50–75% of cells positive); 4 (75–90% of cells positive); 5 (>90% of cells positive).